[1] Goldfrank, L.R., Goldfrank's Toxicologic Emergencies 9th Ed. 2011., McGraw-Hill, New York, N.Y., p. 1192

[2] http://www.cesar.umd.edu/cesar/drugs/pcp.asp

[3] https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~GrcFrc:3 antigo 6

[4] Olson, K. R., & Benowitz, N. L. (Eds.). (2007). Poisoning & drug overdose, 300-302. Antigo 9

[5] Goldfrank, L.R., Goldfrank's Toxicologic Emergencies 9th Ed. 2011., McGraw-Hill, New York, N.Y., p. 1192

[6] Bey, T., & Patel, A. (2007). Phencyclidine intoxication and adverse effects: a clinical and pharmacological review of an illicit drug. Western Journa l of Emergency Medicine, 8(1).

[7] Haddad, L. M., & Winchester, J. F. (1983). Clinical management of poisoning and drug overdose. WB Saunders company. Antigo 8

[8] Jushchyshyn, M. I., Wahlstrom, J. L., Hollenberg, P. F., & Wienkers, L. C. (2006). Mechanism of inactivation of human cytochrome P450 2B6 by phencyclidine. Drug metabolism and disposition,34(9), 1523-1529. Antigo 31

[9] Laurenzana, E. M., & Owens, S. M. (1997). Metabolism of phencyclidine by human liver microsomes. Drug metabolism and disposition,25(5), 557-563. Antigo 7

[10] Johnson, K. M., & Jones, S. M. (1990). Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential. Annual review of pharmacology and toxicology, 30(1), 707-750. Antigo 5